Sign in Subscribe
Cable television broadcasting industry

US Government to Pay $1.95 Billion for COVID-19 Vaccine Doses

Strategic Insights

— 1 min read

The U.S. government is taking a significant step to accelerate the development of a COVID-19 vaccine by paying American pharmaceutical giant Pfizer and German biotech firm BioNTech SE $1.95 billion to produce 100 million doses. The deal is part of President Donald Trump's Operation Warp Speed initiative, which aims to deliver 300 million doses of an approved vaccine by January 2021. Pfizer and BioNTech have already shown promise in early-stage human trials, and their vaccine is expected to be tested in a large trial with the goal of seeking regulatory approval as early as October.

Key Takeaways:

  • The U.S. government will pay $1.95 billion to Pfizer and BioNTech SE for 100 million doses of a COVID-19 vaccine, contingent on their successful development of the vaccine.
  • The deal is part of the Operation Warp Speed initiative, aiming to deliver 300 million doses of an approved vaccine by January 2021.
  • Pfizer and BioNTech's vaccine has shown promise in early-stage human trials and is expected to be tested in a large trial.
  • HHS Secretary Alex Azar mentioned the possibility of buying 500 million additional doses of the vaccine, contingent on their safety and effectiveness.
  • The vaccine is expected to be ready to seek regulatory approval as early as October, pending successful ongoing studies.
  • Pfizer and BioNTech hope to deliver up to 100 million doses by the end of 2020.

Statistics:

  • $1.95 billion: The amount the U.S. government will pay to Pfizer and BioNTech SE for 100 million doses of a COVID-19 vaccine.
  • 100 million: The number of vaccine doses Pfizer and BioNTech are expected to produce.
  • 300 million: The goal of the Operation Warp Speed initiative, aiming to deliver approved vaccine doses by January 2021.
  • 500 million: The number of additional vaccine doses the U.S. government might buy, contingent on their safety and effectiveness.
  • 2020: The year by which Pfizer and BioNTech hope to deliver up to 100 million vaccine doses.

Sources:

  • Voice of America (VOA)

Read more